Every trade that managers of Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) disclose to SEDI is tracked on this page. The past year has been quiet: not a single insider filing for Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.). The previous disclosure was published on 14 November 2019.
The full history, which starts in 2016, counts 4 purchases against 15 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 42 declarations
Emerald Health Therapeutics, Inc. is a Canadian company focused on the research and development of cannabis-based products. It operates on the Toronto Stock Exchange under the symbol XTSE.